Pharma Groups Want Price Maintenance for Patented Meds, Payer Sees It “Natural” to Rectify Gap: Chuikyo

Major pharma industry organizations of Japan, the US, and Europe on May 12 called for a system to maintain drug prices for the duration of patent protection, reiterating their requests to revisit the current price maintenance premium (PMP) and re-pricing...read more